Related Experiment Video
Updated: Sep 27, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues
1Psychiatric Hospital, Ludwig-Maximilian-University, Munich, Germany. hans-juergen.moeller@psy.med.uni-muenchen.de
Abstract:
High expectations have been put into new/atypical neuroleptics for the treatment of schizophrenia: the higher extrapyramidal-motor tolerability and better efficacy in treating negative symptoms supposedly result in a more favourable influencing of the overall course of the disease and in a higher quality of life for the patients. This article will report about the state of evaluation and therapeutic advantages of new/atypical neuroleptics, and thereby deal with problems of definition and methodology. It also describes differences in the unwanted adverse events profile of the different new/atypical antipsychotics.
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...